Virologic rebound observed in 20% of patients

<p>An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20 percent of patients treated with nirmatrelvir-ritonavir (N-R) versus about 2 percent of those who did not receive treatment. The findings are published in Annals of Internal Medicine.</p>

Related Keywords

Massachusetts ,United States ,Markj Siedner , ,Method Of Research ,Internal Medicine Tip Sheet ,United Sates ,Massachusetts General Hospital ,Christina Wee ,Angela Collom ,Haley Bridger ,Rebound With Nirmatrelvir ,